Related Experiment Video
Updated: Aug 9, 2025

09:51
Development and Functional Characterization of Murine Tolerogenic Dendritic Cells
Published on: May 18, 2018
10.8K
TMPRSS2 Impacts Cytokine Expression in Murine Dendritic Cells
Sandra Gunne1, Marie Schwerdtner2, Marina Henke1
1Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP), Theodor-Stern-Kai 7, 60596 Frankfurt am Main, Germany.
Biomedicines
|February 25, 2023
Summary
Transmembrane protease serine 2 (TMPRSS2) affects immune responses differently in dendritic cells. Deleting TMPRSS2 impacts cytokine release in classical DCs and plasmacytoid DCs, depending on toll-like receptor activation.
Area of Science:
- Immunology
- Virology
- Protease Function
Background:
- Transmembrane protease serine 2 (TMPRSS2) is crucial for viral entry.
- Targeting host proteins like TMPRSS2 for antivirals may cause immune side effects.
- The role of TMPRSS2 in dendritic cell (DC) function requires further investigation.
Purpose of the Study:
- To investigate the impact of TMPRSS2 genetic deletion on dendritic cell (DC) function.
- To analyze cytokine production and gene expression in DCs lacking TMPRSS2.
- To understand the differential effects of TMPRSS2 on plasmacytoid DCs (pDCs) and classical DCs (cDCs).
Main Methods:
- Differentiated bone marrow cells from wild-type (WT) and TMPRSS2-deficient (TMPRSS2-/-) mice into pDCs and cDCs.
- Activated DCs using various toll-like receptor (TLR) agonists (resiquimod, ODN 1668).
- Analyzed cytokine release and mRNA expression of key immune-related genes.
Main Results:
- In cDCs, TMPRSS2 deficiency increased IL-12 and IFNγ upon TLR7/8 or TLR9 activation, with reduced IL-10.
- In pDCs, TMPRSS2 deficiency decreased IL-6, IL-10, and IFNγ with resiquimod activation.
- TMPRSS2 deficiency led to reduced IFNα in pDCs activated by ODN 1668, with minimal effects on receptor expression.
Conclusions:
- TMPRSS2 influences DC cytokine release in a TLR-dependent manner.
- TMPRSS2 exhibits distinct roles in pDCs and cDCs, potentially suppressing cytokine release in cDCs and mediating it in pDCs.

